Literature DB >> 15474995

Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells.

George C Cheng1, P Christian Schulze, Richard T Lee, Jeremy Sylvan, Bruce R Zetter, Hayden Huang.   

Abstract

Although intravasation may be a critical rate-limiting step in the metastatic cascade, the role of oxidative stress in intravasation is unknown. We tested the hypothesis that reactive oxygen species (ROS), regulated by thioredoxin interacting protein (Txnip) through the action of thioredoxin (Trx), influence human SK-MEL-28 melanoma cell reverse (basolateral-to-apical) transendothelial migration (TEM) in vitro as a model for intravasation. Reverse transendothelial migration was dose-dependently induced by hydrogen peroxide 2.4-fold for 0.1 microM (P < 0.01) and 3.9-fold for 1 microM (P < 0.001) vs. control, and this effect was blocked by the antioxidant N-acetylcysteine. Overexpression of Txnip by infecting melanoma cells with adenovirus increased TEM 3-fold vs. control (P < 0.001), and this increase was blocked by N-acetylcysteine, indicating a redox-sensitive mechanism. Conversely, thioredoxin overexpression blocked hydrogen peroxide-induced TEM. Exposure to ultraviolet-A radiation increased ROS 1.8-fold (P < 0.01), and this was accompanied by a 45% reduction (P < 0.05) in thioredoxin activity and an 11.4-fold (P < 0.001) increase in Txnip gene expression. These data suggest that TEM of melanoma cells during intravasation is in part mediated by ROS-sensitive cellular signaling cascades, may be controlled by Txnip and its interaction with thioredoxin that in turn modulates cellular levels of oxidative stress, and may be initiated by ultraviolet-A induction of this cascade.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474995     DOI: 10.1016/j.yexcr.2004.07.014

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  17 in total

Review 1.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

2.  Disruption of GRM1-mediated signalling using riluzole results in DNA damage in melanoma cells.

Authors:  Brian A Wall; Janet Wangari-Talbot; Seung S Shin; Devora Schiff; Jairo Sierra; Lumeng J Yu; Atif Khan; Bruce Haffty; James S Goydos; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2014-01-22       Impact factor: 4.693

3.  Hepatitis B virus X protein promotes hepatocellular carcinoma invasion and metastasis via upregulating thioredoxin interacting protein.

Authors:  Zhiliang He; Youjia Yu; Yunhong Nong; Lingyao Du; Cong Liu; Yong Cao; Lang Bai; Hong Tang
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

Review 4.  Thioredoxin in the cardiovascular system.

Authors:  Cameron J World; Hideyuki Yamawaki; Bradford C Berk
Journal:  J Mol Med (Berl)       Date:  2006-10-05       Impact factor: 4.599

Review 5.  Reactive oxygen species in cancer.

Authors:  Geou-Yarh Liou; Peter Storz
Journal:  Free Radic Res       Date:  2010-05

Review 6.  Oxidative stress, inflammation, and cancer: how are they linked?

Authors:  Simone Reuter; Subash C Gupta; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Free Radic Biol Med       Date:  2010-09-16       Impact factor: 7.376

7.  Regulation of thioredoxin by ceramide in retinal pigment epithelial cells.

Authors:  Parameswaran G Sreekumar; Yi Ding; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

Review 8.  Tumor cell intravasation.

Authors:  Serena P H Chiang; Ramon M Cabrera; Jeffrey E Segall
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-13       Impact factor: 4.249

9.  The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response.

Authors:  Amanda F Baker; Terry Landowski; Robert Dorr; Wendy R Tate; Jaime M C Gard; Breonna E Tavenner; Tomislov Dragovich; Amy Coon; Garth Powis
Journal:  Clin Cancer Res       Date:  2007-06-01       Impact factor: 12.531

10.  Thioredoxin binding protein (TBP)-2/Txnip and α-arrestin proteins in cancer and diabetes mellitus.

Authors:  Hiroshi Masutani; Eiji Yoshihara; So Masaki; Zhe Chen; Junji Yodoi
Journal:  J Clin Biochem Nutr       Date:  2011-10-26       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.